ORI
LGND icon

Oak Ridge Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Oak Ridge Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,091
Closed -$3.11M – 177
2020
Q4 		$3.11M Sell
50,091
-13,385
-21% -$763K 0.27% 110
2020
Q3 		$3.77M Sell
63,476
-28,238
-31% -$1.93M 0.29% 105
2020
Q2 		$6.4M Sell
91,714
-7,468
-8% -$473K 0.54% 73
2020
Q1 		$4.5M Sell
99,182
-12,973
-12% -$735K 0.46% 83
2019
Q4 		$7.3M Sell
112,155
-13,660
-11% -$913K 0.54% 74
2019
Q3 		$7.81M Sell
125,815
-55,167
-30% -$3.46M 0.59% 72
2019
Q2 		$12.9M Sell
180,982
-20,741
-10% -$1.53M 0.89% 42
2019
Q1 		$15.8M Sell
201,723
-118,505
-37% -$8.98M 1.01% 29
2018
Q4 		$27.1M Sell
320,228
-19,044
-6% -$2.03M 1.95% 6
2018
Q3 		$58.1M Sell
339,272
-23,221
-6% -$3.5M 3.21% 1
2018
Q2 		$46.8M Sell
362,493
-33,740
-9% -$3.76M 2.65% 2
2018
Q1 		$40.8M Sell
396,233
-118,445
-23% -$11.7M 2.27% 5
2017
Q4 		$44M Sell
514,678
-185,365
-26% -$16.1M 2.1% 4
2017
Q3 		$59.5M Sell
700,043
-207,419
-23% -$16.4M 2.42% 1
2017
Q2 		$68.7M Sell
907,462
-7,138
-0.8% -$499K 2.19% 3
2017
Q1 		$60.4M Sell
914,600
-154,750
-14% -$10.2M 2.03% 9
2016
Q4 		$67.8M Sell
1,069,350
-229,115
-18% -$14.5M 2.2% 7
2016
Q3 		$82.7M Sell
1,298,465
-92,450
-7% -$6.79M 2.15% 12
2016
Q2 		$103M Sell
1,390,915
-118,298
-8% -$8.78M 2.66% 6
2016
Q1 		$101M Sell
1,509,213
-22,612
-1% -$1.37M 2.54% 5
2015
Q4 		$104M Sell
1,531,825
-4,881
-0.3% -$301K 2.48% 4
2015
Q3 		$82.1M Buy
1,536,706
+759,294
+98% +$46.1M 1.96% 14
2015
Q2 		$48.9M Buy
777,412
+53,960
+7% +$2.94M 1.04% 38
2015
Q1 		$34.8M Buy
+723,452
New +$27.7M 0.78% 48

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Oak Ridge Investments's LGND Position: Q1 2021 in Review

Oak Ridge Investments sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 50,091 shares — an estimated $3.11M sold.

Oak Ridge Investments first reported a position in LGND in Q1 2015 and held it in 24 quarters. The position peaked at $104M in Q4 2015. 227 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • Oak Ridge Investments reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Oak Ridge Investments sold 50,091 Ligand Pharmaceuticals shares in Q1 2021, an estimated $3.11M.
  • Oak Ridge Investments first reported a position in Ligand Pharmaceuticals in Q1 2015 and held it in 24 quarters.
  • Oak Ridge Investments's Ligand Pharmaceuticals position peaked at $104M in Q4 2015.
  • 227 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on Oak Ridge Investments's 13F filing for Q1 2021, filed 4 May 2021.